SS
NXTM

Steve Schonfeld’s NxStage Medical Inc. NXTM Stock Holding History

Steve Schonfeld’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,754
Closed -$316K – 861
2017
Q1 		$316K Buy
+11,754
New +$325K 0.03% 458

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Steve Schonfeld's NXTM Position: Q2 2017 in Review

Steve Schonfeld sold out of NxStage Medical Inc. (NXTM) in Q2 2017, closing a stake of 11,754 shares — an estimated $316K sold.

Steve Schonfeld first reported a position in NXTM in Q1 2017 and held it in 1 quarter. The position peaked at $316K in Q1 2017. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

  • Steve Schonfeld reported no remaining NxStage Medical Inc. position as of Q2 2017 after selling out during the quarter.
  • Steve Schonfeld sold 11,754 NxStage Medical Inc. shares in Q2 2017, an estimated $316K.
  • Steve Schonfeld first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 1 quarter.
  • Steve Schonfeld's NxStage Medical Inc. position peaked at $316K in Q1 2017.
  • 163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.